Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Cited by (1,002)

Items 801–900 of 1,002

1. Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19
   Teodor‐D. Brumeanu, Pooja Vir, Ahmad Faisal Karim, Swagata Kar, Dalia Benetiene, Megan Lok, Jack J. Greenhouse, Tammy Putman-Taylor, Christopher Kitajewski, Kevin K. Chung et al. · 2022 · Human Vaccines & Immunotherapeutics
2. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
   Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology
3. SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype
   Kazutaka Terahara, Takashi Sato, Yu Adachi, Keisuke Tonouchi, Taishi Onodera, Saya Moriyama, Lin Sun, Tomohiro Takano, Ayae Nishiyama, Ai Kawana‐Tachikawa et al. · 2022 · iScience
4. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study
   Makhabbat S. Bekbossynova, Lyudmila Akhmaltdinova, Kuanysh Dossybayeva, Ainur Tauekelova, Zauresh Smagulova, Tatyana Tsechoeva, Gulsimzhan Turebayeva, Aliya Sailybayeva, Zhanar Kalila, Tahmina Mirashirova et al. · 2022 · Respiratory Research
5. Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology
   Mohamed M. Shamseldin, Ashley Zani, Adam Kenney, John Parker Evans, Cong Zeng, Kaitlin A. Read, Kyle Caution, Jesse M. Hall, Jessica Marlene Brown, Gilian Gunsch et al. · 2023 · The Journal of Immunology
6. Influenza-A mediated pre-existing immunity levels to SARS-CoV-2 could predict early COVID-19 outbreak dynamics
   Nerea Martín Almazán, Afsar Rahbar, Marcus Carlsson, Tove Hoffman, Linda Kolstad, Bengt J. Rönnberg, Mattia Russel Pantalone, Ilona Lewensohn‐Fuchs, Anna Nauclér, Mats Ohlin et al. · 2023 · iScience
7. What makes SARS‐CoV‐2 unique? Focusing on the spike protein
   Jingbo Qian, Shi-Chang Zhang, Fang Wang, Jinming Li, Jiexin Zhang · 2024 · Cell Biology International
8. Prevalence of Current and Past SARS-CoV-2 Infections among Police Employees in Poland, June–July 2020
   Mariusz Gujski, Mateusz Jankowski, Jarosław Pinkas, Waldemar Wierzba, Piotr Samel‐Kowalik, Artur Zaczyński, Piotr Jędrusik, Igor Pańkowski, Grzegorz Juszczyk, Kamil Rakocy et al. · 2020 · Journal of Clinical Medicine
9. Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
   Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, Ahmed O. Shalash, Michael Joyce, Holly A. Saffran, Christopher J. Day, Ailin Lepletier, Belinda L. Spillings, Jamie-Lee S. Mills et al. · 2021 · Clinical & Translational Immunology
10. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
    Mario Poljak, Anja Oštrbenk, Erik Štrumbelj, Polona Maver Vodičar, Vasja Vehovar, Katarina Resman Rus, Miša Korva, Nataša Knap, Katja Seme, Miroslav Petrovec et al. · 2021 · Clinical Microbiology and Infection
11. Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia
    Zheng Quan Toh, Rachel A. Higgins, Lien Anh Ha Do, Karin Rautenbacher, Francesca L. Mordant, Kanta Subbarao, Kate Dohle, Jill Nguyen, Andrew C. Steer, Shidan Tosif et al. · 2021 · Emerging infectious diseases
12. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction
    Désirée E. Larenas‐Linnemann, José Antonio Ortega‐Martell, María Virginia Blandón-Vijil, Noel Rodríguez‐Pérez, Jorge Agustin Luna-Pech, Alan Estrada-Cardona, Alfredo Arias‐Cruz, Blanca Estela Del-Rio-Navarro, Elsy Maureen Navarrete-Rodriguez, César Fireth Pozo-Beltrán et al. · 2021 · Allergy and Asthma Proceedings
13. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions
    Michael J. Peluso, Joanna L. Donatelli, Timothy J. Henrich · 2021 · Translational research
14. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
    Kristin Greve-Isdahl Mohn, Geir Bredholt, Fan Zhou, Anders Madsen, Therese Bredholt Onyango, Elisabeth Berg Fjelltveit, Sarah Larteley Lartey, Karl Albert Brokstad, Diego M. Cantoni, Martin Mayora Neto et al. · 2022 · PLoS ONE
15. Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis
    Sammita Satyanarayan, Neha Safi, Tali R. Sorets, Susan Filomena, Yi-Nan Zhang, Sylvia Klineova, Michelle T. Fabian, Sam H. Horng, Stephanie K. Tankou, Aaron Miller et al. · 2022 · Multiple Sclerosis and Related Disorders
16. Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
    Douglas F. Lake, Alexa J. Roeder, María J. González‐Moa, Megan A. Koehler, Erin J. Kaleta, Paniz Jasbi, John Vanderhoof, Davis McKechnie, Jack Forman, Baylee A. Edwards et al. · 2022 · Communications Medicine
17. Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
    Hongguan Xing, Liyan Zhu, Pingping Wang, Guoping Zhao, Zhihua Zhou, Yi An Yang, Hong Zou, Xing Yan · 2022 · Frontiers in Immunology
18. Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
    Clara Udaondo, Carmen Cámara, Laura Miguel‐Berenguel, Rosa Alcobendas, Celia Muñoz-Gómez, Claudia Millán Longo, Blanca Díaz – Delgado, Iker Falces‐Romero, Mariana Díaz Almirón, Jordi Ochando et al. · 2022 · Pediatric Rheumatology
19. Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
    Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, Jaime S. Rosa Duque, Samuel M. S. Cheng, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Issan Yee San Tam et al. · 2022 · Signal Transduction and Targeted Therapy
20. T-cell exhaustion in COVID-19: what do we know?
    Roderick Chen-Camaño, Rodrigo DeAntonio, Sandra López‐Vergès · 2025 · Frontiers in Immunology
21. Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report
    Jessica Ferguson, Kanagavel Murugesan, Niaz Banaei, Anne Y. Liu · 2021 · International Journal of Infectious Diseases
22. Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
    Adrian Rice, Mohit Verma, Emily A. Voigt, Peter Battisti, Samuel Beaver, Sierra Reed, Kyle Dinkins, Shivani Mody, Lise Zakin, Shiho Tanaka et al. · 2022 · Frontiers in Immunology
23. Comparison between enzyme‐linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS‐CoV‐2 after symptomatic COVID‐19
    Juliette Villemonteix, Laure Cohen, Amélie Guihot, Valérie Guérin, Clémentine Moulin, Marion Caséris, Agnès Carol, Stéphane Bonacorsi, Guislaine Carcelain · 2022 · Immunity Inflammation and Disease
24. Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
    Shoumit Dey, Helen M. Ashwin, Luke Milross, Bethany Hunter, Joaquim Majo, Andrew J. Filby, Andrew John Fisher, Paul Martin Kaye, Dimitris Lagos · 2023 · Clinical & Experimental Immunology
25. Extracellular vesicles in COVID-19 convalescence can regulate T cell metabolism and function
    M. George, Jenifer Sanchez, Christina M. Rollings, David J. Fear, Peter Miles Irving, Linda V. Sinclair, Anna Schurich · 2023 · iScience
26. Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
    Viviane M. Andrade, Igor Maricic, Richa Kalia, Lauren A Jachimowicz, Olivia Bedoya, Daniel W. Kulp, Laurent M. P. F. Humeau, Trevor R.F. Smith · 2023 · Human Vaccines & Immunotherapeutics
27. Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults
    Kohei Kometani, Takaaki Yorimitsu, Norihide Jo, Erina Yamaguchi, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Yoshitaka Tsujimoto, Ayana Sunami, Mengqian Li et al. · 2024 · Frontiers in Immunology
28. Coronavirus disease 2019 population-based prevalence, risk factors, hospitalization, and fatality rates in southern Brazil
    Rafael V. Picon, Ioná Carreno, André Anjos da Silva, Márcio Mossmann, Gabriela Laste, Guilherme de Campos Domingues, Lara Faria Fernandes Heringer, Brenda Rodrigues Gheno, Letícia Leão Alvarenga, Magali Conte · 2020 · International Journal of Infectious Diseases
29. COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
    Jade Khalife, Derrick VanGennep · 2021 · Epidemiology and Health
30. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study
    Bali Zhao, Maohua Zhong, Qingyu Yang, Ke Hong, Jianbo Xia, Xia Li, Ying Liu, Yao-Qing Chen, Jingyi Yang, Chaolin Huang et al. · 2021 · Virologica Sinica
31. Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations
    Sanmoy Pathak, Mohit Kumar Jolly, Dipankar Nandi · 2021 · Human Vaccines & Immunotherapeutics
32. Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
    C. Riou, Georgia Schäfer, E. du Bruyn, R. Goliath, C. Stek, H. Mou, D. Hung, K. Wilkinson, R. Wilkinson · 2021 · European Respiratory Journal
33. Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level
    Hannah Charlotte Copley, Loren A. Gragert, Andrew R. Leach, Vasilis Kosmoliaptsis · 2021 · Frontiers in Immunology
34. Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
    Mohd. Raeed Jamiruddin, Md. Ahsanul Haq, Mohib Ullah Khondoker, Tamanna Ali, Firoz Ahmed, Shahad Saif Khandker, Md. Irfan Jawad, Rubel Hossain, Sohel Ahmed, Sabita Rezwana Rahman et al. · 2021 · Expert Review of Vaccines
35. Decisive conditions for strategic vaccination against SARS-CoV-2
    Lucas Böttcher, Jan Nagler · 2021 · Chaos An Interdisciplinary Journal of Nonlinear Science
36. Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit
    Dmitry A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, Olga M. Strizhakova, Колесник Светлана Владимировна, Хамитов Равиль Авгатович · 2021 · Biological Products Prevention Diagnosis Treatment
37. Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses
    Emelie Marklund, Susannah Leach, Kristina Nyström, Anna Lundgren, Jan‐Åke Liljeqvist, Staffan Nilsson, Aylin Yilmaz, Lars‐Magnus Andersson, Mats Bemark, Magnus Gisslén · 2021 · Frontiers in Immunology
38. T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial
    Lisa Blixt, David J. Wullimann, Soo Aleman, Jeanette Lundin, Puran Chen, Yu Gao, Angélica Cuapio, Mira Akber, Joshua L. Lange, Olga Rivera‐Ballesteros et al. · 2022 · Haematologica
39. The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
    Gang Xu, Furong Qi, Haiyan Wang, Yu Liu, Xin Wang, Rongrong Zou, Jing Yuan, Xuejiao Liao, Yang Liu, Shuye Zhang et al. · 2022 · Frontiers in Immunology
40. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs
    Hoang Oanh Nguyen, Tiziana Schioppa, Laura Tiberio, Fabrizio Facchinetti, Gino Villetti, Maurizio Civelli, Annalisa Del Prete, Francesca Sozio, Carolina Gaudenzi, Mauro Passari et al. · 2022 · Frontiers in Immunology
41. COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
    Yusuke Ito, Akira Honda, Mineo Kurokawa · 2022 · Clinical Lymphoma Myeloma & Leukemia
42. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
    Joseph Torresi, Melissa Anne Edeling, Terry M. Nolan, Dale Ian Godfrey · 2022 · Frontiers in Immunology
43. Where do T cell subsets stand in SARS-CoV-2 infection: an update
    Mohammad Tarique, Mohd Suhail, Huma Naz, Naoshad Muhammad, Shams S. M. Tabrez, Torki A. Zughaibi, Adel Mohammed Abuzenadah, Anwar M. Hashem, Hari Shankar, Chaman Saini et al. · 2022 · Frontiers in Cellular and Infection Microbiology
44. New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
    Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Allergy
45. Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and more
    Victor Alexandru Constantinescu, Katja Akgün, Tjalf Ziemssen · 2022 · Expert Opinion on Drug Metabolism & Toxicology
46. Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19
    Hakim Hocini, Aurélie Wiedemann, Fabiola Blengio, Cécile Lefebvre, Minerva Cervantes-Gonzalez, Emile Foucat, Pascaline Tisserand, Mathieu Surénaud, Séverin Coléon, Mélanie Prague et al. · 2023 · Journal of Clinical Immunology
47. Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity
    Katharina Kocher, Felix Drost, Abel Mekonnen Tesfaye, Carolin Moosmann, Christine Schülein, Myriam Grotz, Elvira D’Ippolito, Frederik Graw, Bernd M. Spriewald, Dirk Hans Busch et al. · 2025 · Science Immunology
48. Case Report: Sars-CoV-2 Infection in a Vaccinated Individual: Evaluation of the Immunological Profile and Virus Transmission Risk
    Claudia Strafella, Valerio Caputo, Gisella Guerrera, Andrea Termine, Carlo Fabrizio, Raffaella Cascella, Mario Picozza, Carlo Caltagirone, Angelo Rossini, Maria Pia Balice et al. · 2021 · Frontiers in Immunology
49. Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines
    Yu‐Sun Lee, So‐Hee Hong, Hyo‐Jung Park, Ho‐Young Lee, Ji-Yeon Hwang, Seo Yeon Kim, Jun Won Park, Kang-Seuk Choi, Je Kyung Seong, Sang‐In Park et al. · 2021 · Frontiers in Microbiology
50. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents
    Ilaria Schiavoni, Annapina Palmieri, Eleonora Olivetta, Pasqualina Leone, Anna Di Lonardo, Alessandra Mazzoli, Carmine Cafariello, Alba Malara, Anna Teresa Palamara, Raffaele Antonelli Incalzi et al. · 2022 · Journal of the American Medical Directors Association
51. Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
    Nina Le Bert, Taraz Samandari · 2024 · Cellular and Molecular Immunology
52. Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 [PIMS-TS] in a Patient Receiving Infliximab Therapy for Inflammatory Bowel Disease
    Joseph Meredith, Cher-Antonia Khedim, Paul Henderson, David C Wilson, Richard Kay Russell · 2020 · Journal of Crohn s and Colitis
53. Daily Forecasting of Regional Epidemics of Coronavirus Disease with Bayesian Uncertainty Quantification, United States
    Yen Ting Lin, Jacob Neumann, Ely F. Miller, Richard G. Posner, Abhishek Mallela, Cosmin Safta, Jaideep Ray, Gautam Malviya Thakur, Supriya Chinthavali, William S. Hlavacek · 2021 · Emerging infectious diseases
54. Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March–August, 2020
    Travis W Lim, Mark J. Delorey, Nicolette C. Bestul, Michael A Johannson, Carrie Reed, Aron J. Hall, Alicia M. Fry, Chris Edens, Vera A. Semenova, Li Han et al. · 2021 · Clinical Infectious Diseases
55. Potential Cross-Reactive Immunity to COVID-19 Infection in Individuals With Laboratory-Confirmed MERS-CoV Infection: A National Retrospective Cohort Study From Saudi Arabia
    Anas A. Khan, Ahmed Alahmari, Yasir S. Almuzaini, Fahad Abdulrahman Alamri, ‏Yousef Alsofayan, Alhanouf Aburas, Saleh Al‐Muhsen, Maria D. Van Kerkhove, Saber Yezli, Gregory R. Ciottone et al. · 2021 · Frontiers in Immunology
56. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
57. Long-Term Accuracy of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay and Its Application in Household Investigation
    Kanagavel Murugesan, Prasanna Jagannathan, Jonathan Altamirano, Yvonne Maldonado, Hector Fabio Bonilla, Karen Blake Jacobson, Julie Parsonnet, Jason Randolph Andrews, Run‐Zhang Shi, Scott Dexter Boyd et al. · 2022 · Clinical Infectious Diseases
58. COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
    Niyati Jakharia, Aruna K Subramanian, Adrienne E. Shapiro · 2022 · Infectious Disease Clinics of North America
59. Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach
    Alexandru Tîrziu, Virgil Păunescu · 2022 · Vaccines
60. Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
    Christophe Capelle, Séverine Ciré, Olivia Domingues, Isabelle Ernens, Fanny Hedin, Aurélie Fischer, Chantal J. Snoeck, Wim Ammerlaan, Maria Konstantinou, Kamil Grzyb et al. · 2022 · Cell Reports Medicine
61. SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway
    Marjut Sarjomaa, Lien My Diep, Chi Zhang, Yngvar Tveten, Harald Reiso, Carina Thilesen, Svein Arne Nordbø, Kristine Karlsrud Berg, Ingeborg Sundsvalen Aaberge, Neil E. Pearce et al. · 2022 · PLoS ONE
62. Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
    Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Yoshiyuki Yahagi, Yoko Tabe, Naoto Tamura, Sachiko Miyake · 2022 · Scientific Reports
63. Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
    Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, Laura S. Gong, Mary Ann Hausner, Jennifer A. Fulcher, Paul A Krogstad, Scott G. Kitchen, Kathie G. Ferbas, Nicole H. Tobin et al. · 2023 · Frontiers in Immunology
64. Could Naturally Occurring Coronaviral Diseases in Animals Serve as Models for COVID-19? A Review Focusing on the Bovine Model
    Jonas Johansson Wensman, Maria Stokstad · 2020 · Pathogens
65. Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection
    Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney · 2021 · The FASEB Journal
66. Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteins
    Jieping Deng, Junping Pan, Minghui Qiu, Lipeng Mao, Zhigang Wang, Guodong Zhu, Lijuan Gao, Jun Su, Yutian Hu, Oscar Junhong Luo et al. · 2021 · Journal of Leukocyte Biology
67. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape
    Marco Antônio M. Pretti, Rômulo Gonçalves Agostinho Galvani, Nicole de Miranda Scherer, Alessandro S. Farias, Mariana Boroni · 2022 · Infection Genetics and Evolution
68. COVID-19 Serology in Oncology Staff Study: Understanding SARS-CoV-2 in the Oncology Workforce
    David Mordechai Favara, A. Cooke, Rainer Döffinger, S Houghton, I Budriunaite, Sophie Bossingham, Karen McAdam, Pippa G. Corrie, Nicola L. Ainsworth · 2020 · Clinical Oncology
69. SARS-CoV-2 Infection and Antibody Seroprevalence among UK Healthcare Professionals Working with Cancer Patients during the First Wave of the COVID-19 Pandemic
    David Mordechai Favara, Karen McAdam, A. Cooke, Alex Bordessa-Kelly, Ieva Budriunaite, Sophie Bossingham, Sally Houghton, Rainer Döffinger, Nicola L. Ainsworth, Pippa G. Corrie · 2021 · Clinical Oncology
70. T‐cell response after first dose of BNT162b2 SARS‐CoV‐2 vaccine among healthcare workers with previous infection or cross‐reactive immunity
    José L. Casado, Johannes Häemmerle, Pilar Vizcarra, Mario Rodríguez-Domínguez, Tamara Velasco, Hector Velasco, Elena Centenera, Beatriz Romero‐Hernández, Marina Fernández-Escribano, Alejandro Vallejo · 2021 · Clinical & Translational Immunology
71. Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
    Ivan Adamec, Dunja Rogić, Monika-Gabriele Penz, Carola Braun, Mario Habek · 2021 · Journal of Neuroimmunology
72. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
    Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu · 2022 · Frontiers in Immunology
73. Lung T cell response in COVID-19
    Mehrnoush Hadaddzadeh Shakiba, Ioanna D. Gemünd, Marc Beyer, Lorenzo Bonaguro · 2023 · Frontiers in Immunology
74. Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
    Alexandra Vujkovic, My Kieu Ha, Tessa de Block, Lida van Petersen, Isabel Brosius, Caroline Theunissen, Sabrina H. van Ierssel, Esther Bartholomeus, Wim J. Adriaensen, Guido L. Vanham et al. · 2023 · The Journal of Infectious Diseases
75. Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
    Julio Carrera Montoya, Simon Collett, Daniel Fernandez‐Ruiz, Linda Earnest, Melissa Anne Edeling, Ashley Huey Yiing Yap, Chinn Yi Wong, James P. Cooney, Kathryn C. Davidson, Jason Roberts et al. · 2024 · Organoids
76. Longitudinal Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Immunity Over 2 Years Following Vaccination and Infection
    Anna Karina Juhl, Lisa Loksø Dietz, Ole Schmeltz Søgaard, Joanne Reekie, Henrik Ib Nielsen, Işık Somuncu Johansen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Tomas Østergaard Jensen et al. · 2024 · The Journal of Infectious Diseases
77. Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics
    Jun-Guo Zhang · 2024 · Heliyon
78. Membrane tension may define the deadliest virus infection
    Md Mahmudur Rahman, Stuart J. Williams · 2020 · Colloids and Interface Science Communications
79. Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
    Hengsheng Fang, Adam D. Wegman, Kianna Ripich, Heather Friberg, Jeffrey R. Currier, Stephen James Thomas, Timothy P. Endy, Adam Tully Waickman · 2021 · Viruses
80. Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen
    Chinh Tran-To Su, Wai‐Heng Lua, Jun-Jie Poh, Wei‐Li Ling, Joshua Yi Yeo, Samuel Ken‐En Gan · 2021 · Frontiers in Immunology
81. Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
    T. Nomura, Hiroyuki Yamamoto, M. Nishizawa, T. Hau, S. Harada, Hiroshi Ishii, Sayuri Seki, Midori Nakamura-Hoshi, Midori Okazaki, Sachie Daigen et al. · 2021 · bioRxiv
82. PopCover-2.0. Improved Selection of Peptide Sets With Optimal HLA and Pathogen Diversity Coverage
    Jonas Birkelund Nilsson, Alba Grifoni, Alison Tarke, Alessandro Sette, Morten Nielsen · 2021 · Frontiers in Immunology
83. Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection
    Yu Fu, Fang Chen, Lifen Cui, Yue Zhao, Henan Zhang, Shuang Fu, Jihong Zhang · 2021 · Vaccines
84. High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders
    Dalila Mele, Anna Calastri, Eugenia Maiorano, Antonella Cerino, Michele Sachs, Barbara Oliviero, Stefania Mantovani, Fausto Baldanti, Raffaele Bruno, Marco Benazzo et al. · 2021 · Frontiers in Immunology
85. Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19
    Xiaodong Tian, Zhihua Bai, Ying Cao, Haizhou Liu, Di Liu, Wenjun Liu, Jing Li · 2022 · Viruses
86. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals
    Nadejda Beliakova‐Bethell, Kathirvel Maruthai, Ruijie Xu, Liliana C. M. Salvador, Ankita Garg · 2022 · Frontiers in Immunology
87. Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
    Annamaria Paolini, Rebecca Borella, Anita Neroni, Domenico Lo Tartaro, Marco Mattioli, Lucia Fidanza, Alessia Di Nella, Elena Santacroce, Licia Gozzi, Stefano Busani et al. · 2022 · International Journal of Molecular Sciences
88. Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2
    Salvatore Rotundo, Eleonora Vecchio, Antonio Abatino, Caterina Giordano, Serafina Mancuso, Maria Teresa Tassone, Chiara Costa, Alessandro Russo, Enrico Maria Trecarichi, Giovanni Cuda et al. · 2022 · International Journal of Infectious Diseases
89. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients
    Fatemeh Kiaee, Hamidreza Jamaati, Heshmat Shahi, Neda Dalil Roofchayee, Mohammad Varahram, Gert Folkerts, Johan Garssen, Ian Michael Adcock, Esmaeil Mortaz · 2022 · Scientific Reports
90. Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
    Domenico Lo Tartaro, Annamaria Paolini, Marco Mattioli, Julian Swatler, Anita Neroni, Rebecca Borella, Elena Santacroce, Alessia Di Nella, Licia Gozzi, Stefano Busani et al. · 2023 · Frontiers in Immunology
91. Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
    Lorenzo Federico, Brandon Malone, Simen Tennøe, Viktoriia Chaban, Julie Røkke Osen, Murat Gainullin, Eva Smorodina, Hassen Kared, Rahmad Akbar, Victor Greiff et al. · 2023 · Frontiers in Immunology
92. Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response
    Claire Butters, Ntombi Benede, Thandeka Moyo-Gwete, Simone I. Richardson, Ursula Karin Rohlwink, Muki Shehu Shey, Frances Ayres, Nelia P. Manamela, Zanele Makhado, Sashkia R. Balla et al. · 2023 · Clinical Immunology
93. Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines
    Medha Medha, Parul Bhatt, P. Priyanka, Monika Sharma, Sadhna Sharma · 2021 · In Silico Pharmacology
94. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach
    Patil Pranita Uttamrao, Chakkarai Sathyaseelan, L. Ponoop Prasad Patro, Thenmalarchelvi Rathinavelan · 2021 · Frontiers in Immunology
95. T cell responses to SARS-CoV-2 in humans and animals
    Sameer-ul-Salam Mattoo, Jinjong Myoung · 2022 · The Journal of Microbiology
96. Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19
    Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew Pellan Cheng, Donald Cuong Vinh, Philippe Boutet, Robbert G. Van der Most, François P. Roman et al. · 2022 · Nature Communications
97. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
    Patrick Orestes de Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, Marcílio Jorge Fumagalli, Isabella Cristina Hirako, Emiliano Rosa Oliveira, Maria M. Figueiredo, Alex Fiorini de Carvalho, Daniel Doro, Luciana Benevides et al. · 2023 · npj Vaccines
98. Pathogenesis Guided Therapeutic Management of COVID-19: An Immunological Perspective
    Ashutosh Kumar, Pranav Prasoon, Prakash Singh Shekhawat, Vikas Pareek, Muneeb A. Faiq, Chiman Kumari, Ravi Kant Narayan, Maheswari Kulandhasamy, Kamla Kant · 2020 · International Reviews of Immunology
99. Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
    Can Yue, Pengyan Wang, Jinmin Tian, George F. Gao, Kefang Liu, William J. Liu · 2023 · International Journal of Biological Sciences
100. Designing a novel multi-epitopes pan-vaccine against SARS-CoV-2 and seasonal influenza: in silico and immunoinformatics approach
     Matin Fathollahi, Hamid Motamedi, Hadi Hossainpour, Ramin Abiri, Mohsen Shahlaei, Sajad Moradi, Shirin Dashtbin, Jale Moradi, Amirhooshang Alvandi · 2023 · Journal of Biomolecular Structure and Dynamics